DOT Diary Optimization Pilot: A Pilot Study to Optimize the DOT Diary App to Measure PrEP Adherence

NCT03387462 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Adherence, Medication
Risk Behavior
Pre-Exposure Prophylaxis
HIV Prevention

Interventions

DRUG: Emtricitabine / Tenofovir Disoproxil Oral Tablet
OTHER: DOT Diary mobile app

Sponsor

Public Health Foundation Enterprises, Inc.

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]